Back to resultsDry Needling Versus Stretching for Muscle Extensibility
Primary Purpose
Osteoarthritis, Hip
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Dry needling
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis, Hip focused on measuring physiotherapy, stretching, dry needling
Eligibility Criteria
Inclusion Criteria:
- unilateral hip OA diagnosed medically with a X-Ray tess and following the American College of Rheumatology Criteria
Exclusion Criteria:
- Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
- Vascular or neurological disease.
- Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
- DN contraindications or fear of needles
Sites / Locations
- Luis Ceballos Laita
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Dry needling
Stretching
Arm Description
Dry needling of 3 active MTrPs at most.
Stretching of the main hip flexors (rectus femoris, iliopsoas and tensor fasciae latae)
Outcomes
Primary Outcome Measures
muscle extensibility
the examiners assess the muscle extensibility using an inclinomenter
muscle extensibility
the examiners assess the muscle extensibility using an inclinomenter
Secondary Outcome Measures
Stiffness
the examiners assess the stiffness using the WOMAC stiffness subscale
Stiffness
the examiners assess the stiffness using the WOMAC stiffness subscale
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04400825
Brief Title
Dry Needling Versus Stretching for Muscle Extensibility
Official Title
Comparing Dry Needling and Stretching for the Management of Muscle Extensibility in Patients With Hip Osteoarthritis: A Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
May 1, 2020 (Actual)
Primary Completion Date
July 19, 2020 (Actual)
Study Completion Date
July 19, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad de Zaragoza
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Currently several authors have shown the presence of active myofascial trigger points (MTrP) in the muscles surrounding the hip joint that reproduce the symptoms of the patients with hip OA.
Despite of the beneficial effects that have shown may conservative non-pharmacological treatments, there is a lack of studies evaluating the effects of the conservative treatments on muscle extensibility.
According to the new paradigm about the presence of MTrPs, the investigators decided to conduct a randomized clinical trial to compare the effects of DN intervention and stretching protocol on muscle extensibility in patients with hip OA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Hip
Keywords
physiotherapy, stretching, dry needling
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized clinical trial
Masking
Outcomes Assessor
Masking Description
single-blind
Allocation
Randomized
Enrollment
38 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dry needling
Arm Type
Experimental
Arm Description
Dry needling of 3 active MTrPs at most.
Arm Title
Stretching
Arm Type
Active Comparator
Arm Description
Stretching of the main hip flexors (rectus femoris, iliopsoas and tensor fasciae latae)
Intervention Type
Other
Intervention Name(s)
Dry needling
Intervention Description
Dry needling of the active MTrPs following the technique described by Hong et al (1994,1995)
Primary Outcome Measure Information:
Title
muscle extensibility
Description
the examiners assess the muscle extensibility using an inclinomenter
Time Frame
Baseline
Title
muscle extensibility
Description
the examiners assess the muscle extensibility using an inclinomenter
Time Frame
up to 3 weeks
Secondary Outcome Measure Information:
Title
Stiffness
Description
the examiners assess the stiffness using the WOMAC stiffness subscale
Time Frame
Baseline
Title
Stiffness
Description
the examiners assess the stiffness using the WOMAC stiffness subscale
Time Frame
up to 3 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
unilateral hip OA diagnosed medically with a X-Ray tess and following the American College of Rheumatology Criteria
Exclusion Criteria:
Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
Vascular or neurological disease.
Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
DN contraindications or fear of needles
Facility Information:
Facility Name
Luis Ceballos Laita
City
Soria
ZIP/Postal Code
42004
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Dry Needling Versus Stretching for Muscle Extensibility
We'll reach out to this number within 24 hrs